Patient-derived iPSCs link elevated mitochondrial respiratory complex I function to osteosarcoma in Rothmund-Thomson syndrome

Rothmund-Thomson syndrome (RTS) is an autosomal recessive genetic disorder characterized by poikiloderma, small stature, skeletal anomalies, sparse brows/lashes, cataracts, and predisposition to cancer. Type 2 RTS patients with biallelic RECQL4 pathogenic variants have multiple skeletal anomalies an...

Full description

Saved in:
Bibliographic Details
Published inPLoS genetics Vol. 17; no. 12; p. e1009971
Main Authors Jewell, Brittany E., Xu, An, Zhu, Dandan, Huang, Mo-Fan, Lu, Linchao, Liu, Mo, Underwood, Erica L., Park, Jun Hyoung, Fan, Huihui, Gingold, Julian A., Zhou, Ruoji, Tu, Jian, Huo, Zijun, Liu, Ying, Jin, Weidong, Chen, Yi-Hung, Xu, Yitian, Chen, Shu-Hsia, Rainusso, Nino, Berg, Nathaniel K., Bazer, Danielle A., Vellano, Christopher, Jones, Philip, Eltzschig, Holger K., Zhao, Zhongming, Kaipparettu, Benny Abraham, Zhao, Ruiying, Wang, Lisa L., Lee, Dung-Fang
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 29.12.2021
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Rothmund-Thomson syndrome (RTS) is an autosomal recessive genetic disorder characterized by poikiloderma, small stature, skeletal anomalies, sparse brows/lashes, cataracts, and predisposition to cancer. Type 2 RTS patients with biallelic RECQL4 pathogenic variants have multiple skeletal anomalies and a significantly increased incidence of osteosarcoma. Here, we generated RTS patient-derived induced pluripotent stem cells (iPSCs) to dissect the pathological signaling leading to RTS patient-associated osteosarcoma. RTS iPSC-derived osteoblasts showed defective osteogenic differentiation and gain of in vitro tumorigenic ability. Transcriptome analysis of RTS osteoblasts validated decreased bone morphogenesis while revealing aberrantly upregulated mitochondrial respiratory complex I gene expression. RTS osteoblast metabolic assays demonstrated elevated mitochondrial respiratory complex I function, increased oxidative phosphorylation (OXPHOS), and increased ATP production. Inhibition of mitochondrial respiratory complex I activity by IACS-010759 selectively suppressed cellular respiration and cell proliferation of RTS osteoblasts. Furthermore, systems analysis of IACS-010759-induced changes in RTS osteoblasts revealed that chemical inhibition of mitochondrial respiratory complex I impaired cell proliferation, induced senescence, and decreased MAPK signaling and cell cycle associated genes, but increased H19 and ribosomal protein genes. In summary, our study suggests that mitochondrial respiratory complex I is a potential therapeutic target for RTS-associated osteosarcoma and provides future insights for clinical treatment strategies.
AbstractList Rothmund-Thomson syndrome (RTS) is an autosomal recessive genetic disorder characterized by poikiloderma, small stature, skeletal anomalies, sparse brows/lashes, cataracts, and predisposition to cancer. Type 2 RTS patients with biallelic RECQL4 pathogenic variants have multiple skeletal anomalies and a significantly increased incidence of osteosarcoma. Here, we generated RTS patient-derived induced pluripotent stem cells (iPSCs) to dissect the pathological signaling leading to RTS patient-associated osteosarcoma. RTS iPSC-derived osteoblasts showed defective osteogenic differentiation and gain of in vitro tumorigenic ability. Transcriptome analysis of RTS osteoblasts validated decreased bone morphogenesis while revealing aberrantly upregulated mitochondrial respiratory complex I gene expression. RTS osteoblast metabolic assays demonstrated elevated mitochondrial respiratory complex I function, increased oxidative phosphorylation (OXPHOS), and increased ATP production. Inhibition of mitochondrial respiratory complex I activity by IACS-010759 selectively suppressed cellular respiration and cell proliferation of RTS osteoblasts. Furthermore, systems analysis of IACS-010759-induced changes in RTS osteoblasts revealed that chemical inhibition of mitochondrial respiratory complex I impaired cell proliferation, induced senescence, and decreased MAPK signaling and cell cycle associated genes, but increased H19 and ribosomal protein genes. In summary, our study suggests that mitochondrial respiratory complex I is a potential therapeutic target for RTS-associated osteosarcoma and provides future insights for clinical treatment strategies.
Rothmund-Thomson syndrome (RTS) is an autosomal recessive genetic disorder characterized by poikiloderma, small stature, skeletal anomalies, sparse brows/lashes, cataracts, and predisposition to cancer. Type 2 RTS patients with biallelic RECQL4 pathogenic variants have multiple skeletal anomalies and a significantly increased incidence of osteosarcoma. Here, we generated RTS patient-derived induced pluripotent stem cells (iPSCs) to dissect the pathological signaling leading to RTS patient-associated osteosarcoma. RTS iPSC-derived osteoblasts showed defective osteogenic differentiation and gain of in vitro tumorigenic ability. Transcriptome analysis of RTS osteoblasts validated decreased bone morphogenesis while revealing aberrantly upregulated mitochondrial respiratory complex I gene expression. RTS osteoblast metabolic assays demonstrated elevated mitochondrial respiratory complex I function, increased oxidative phosphorylation (OXPHOS), and increased ATP production. Inhibition of mitochondrial respiratory complex I activity by IACS-010759 selectively suppressed cellular respiration and cell proliferation of RTS osteoblasts. Furthermore, systems analysis of IACS-010759-induced changes in RTS osteoblasts revealed that chemical inhibition of mitochondrial respiratory complex I impaired cell proliferation, induced senescence, and decreased MAPK signaling and cell cycle associated genes, but increased H19 and ribosomal protein genes. In summary, our study suggests that mitochondrial respiratory complex I is a potential therapeutic target for RTS-associated osteosarcoma and provides future insights for clinical treatment strategies. Rothmund-Thomson syndrome (RTS) is an autosomal recessive genetic disease characterized by an array of clinical phenotypes affecting multiple tissues. Type 2 RTS is caused by pathogenic variants in the RECQL4 gene encoding the RECQL4 DNA helicase. Type 2 RTS patients are prone to developing multiple primary osteosarcomas and have limited chemotherapy options due to organ toxicities or lifetime limits on active agents such as anthracyclines. There is currently no available RTS model that recapitulates the bone malignancy phenotype in this disease, severely limiting the ability to explore new treatment avenues which are greatly needed for these patients. To overcome this problem, we established a Type 2 RTS disease model using a human induced pluripotent stem cell platform. We then applied an unbiased approach to explore novel molecular mechanisms involved in RECQL4 mutation-induced osteosarcoma to explore therapeutic interventions. Our findings indicate that mitochondrial respiratory complex I is an “Achilles’ heel” of RTS osteosarcoma and that cancers harboring RECQL4 mutations/deletions, in general, may be vulnerable to mitochondrial respiratory complex I inhibition.
Rothmund-Thomson syndrome (RTS) is an autosomal recessive genetic disorder characterized by poikiloderma, small stature, skeletal anomalies, sparse brows/lashes, cataracts, and predisposition to cancer. Type 2 RTS patients with biallelic RECQL4 pathogenic variants have multiple skeletal anomalies and a significantly increased incidence of osteosarcoma. Here, we generated RTS patient-derived induced pluripotent stem cells (iPSCs) to dissect the pathological signaling leading to RTS patient-associated osteosarcoma. RTS iPSC-derived osteoblasts showed defective osteogenic differentiation and gain of in vitro tumorigenic ability. Transcriptome analysis of RTS osteoblasts validated decreased bone morphogenesis while revealing aberrantly upregulated mitochondrial respiratory complex I gene expression. RTS osteoblast metabolic assays demonstrated elevated mitochondrial respiratory complex I function, increased oxidative phosphorylation (OXPHOS), and increased ATP production. Inhibition of mitochondrial respiratory complex I activity by IACS-010759 selectively suppressed cellular respiration and cell proliferation of RTS osteoblasts. Furthermore, systems analysis of IACS-010759-induced changes in RTS osteoblasts revealed that chemical inhibition of mitochondrial respiratory complex I impaired cell proliferation, induced senescence, and decreased MAPK signaling and cell cycle associated genes, but increased H19 and ribosomal protein genes. In summary, our study suggests that mitochondrial respiratory complex I is a potential therapeutic target for RTS-associated osteosarcoma and provides future insights for clinical treatment strategies.
Rothmund-Thomson syndrome (RTS) is an autosomal recessive genetic disorder characterized by poikiloderma, small stature, skeletal anomalies, sparse brows/lashes, cataracts, and predisposition to cancer. Type 2 RTS patients with biallelic RECQL4 pathogenic variants have multiple skeletal anomalies and a significantly increased incidence of osteosarcoma. Here, we generated RTS patient-derived induced pluripotent stem cells (iPSCs) to dissect the pathological signaling leading to RTS patient-associated osteosarcoma. RTS iPSC-derived osteoblasts showed defective osteogenic differentiation and gain of in vitro tumorigenic ability. Transcriptome analysis of RTS osteoblasts validated decreased bone morphogenesis while revealing aberrantly upregulated mitochondrial respiratory complex I gene expression. RTS osteoblast metabolic assays demonstrated elevated mitochondrial respiratory complex I function, increased oxidative phosphorylation (OXPHOS), and increased ATP production. Inhibition of mitochondrial respiratory complex I activity by IACS-010759 selectively suppressed cellular respiration and cell proliferation of RTS osteoblasts. Furthermore, systems analysis of IACS-010759-induced changes in RTS osteoblasts revealed that chemical inhibition of mitochondrial respiratory complex I impaired cell proliferation, induced senescence, and decreased MAPK signaling and cell cycle associated genes, but increased H19 and ribosomal protein genes. In summary, our study suggests that mitochondrial respiratory complex I is a potential therapeutic target for RTS-associated osteosarcoma and provides future insights for clinical treatment strategies.Rothmund-Thomson syndrome (RTS) is an autosomal recessive genetic disorder characterized by poikiloderma, small stature, skeletal anomalies, sparse brows/lashes, cataracts, and predisposition to cancer. Type 2 RTS patients with biallelic RECQL4 pathogenic variants have multiple skeletal anomalies and a significantly increased incidence of osteosarcoma. Here, we generated RTS patient-derived induced pluripotent stem cells (iPSCs) to dissect the pathological signaling leading to RTS patient-associated osteosarcoma. RTS iPSC-derived osteoblasts showed defective osteogenic differentiation and gain of in vitro tumorigenic ability. Transcriptome analysis of RTS osteoblasts validated decreased bone morphogenesis while revealing aberrantly upregulated mitochondrial respiratory complex I gene expression. RTS osteoblast metabolic assays demonstrated elevated mitochondrial respiratory complex I function, increased oxidative phosphorylation (OXPHOS), and increased ATP production. Inhibition of mitochondrial respiratory complex I activity by IACS-010759 selectively suppressed cellular respiration and cell proliferation of RTS osteoblasts. Furthermore, systems analysis of IACS-010759-induced changes in RTS osteoblasts revealed that chemical inhibition of mitochondrial respiratory complex I impaired cell proliferation, induced senescence, and decreased MAPK signaling and cell cycle associated genes, but increased H19 and ribosomal protein genes. In summary, our study suggests that mitochondrial respiratory complex I is a potential therapeutic target for RTS-associated osteosarcoma and provides future insights for clinical treatment strategies.
Audience Academic
Author Park, Jun Hyoung
Lee, Dung-Fang
Zhu, Dandan
Gingold, Julian A.
Jin, Weidong
Eltzschig, Holger K.
Underwood, Erica L.
Wang, Lisa L.
Huo, Zijun
Vellano, Christopher
Jones, Philip
Kaipparettu, Benny Abraham
Liu, Mo
Lu, Linchao
Rainusso, Nino
Zhao, Zhongming
Chen, Shu-Hsia
Xu, An
Huang, Mo-Fan
Liu, Ying
Berg, Nathaniel K.
Zhao, Ruiying
Jewell, Brittany E.
Tu, Jian
Fan, Huihui
Zhou, Ruoji
Chen, Yi-Hung
Bazer, Danielle A.
Xu, Yitian
AuthorAffiliation 10 Department of Anesthesiology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, United States of America
9 Center for Immunotherapy Research, Cancer Center of Excellence, Houston Methodist Research Institute, Houston, Texas, United States of America
11 Department of Neurology, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, United States of America
5 Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America
1 Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, United States of America
8 Department and Institute of Pharmacology, National Yang Ming Chiao Tung University, Taipei, Taiwan
3 Department of Pediatrics, Baylor College of Medicine, Texas Children’s Hospital, Houston, Texas, United States of America
13 Center for Stem Cell and Regenerative Medicine, Th
AuthorAffiliation_xml – name: 1 Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, United States of America
– name: 8 Department and Institute of Pharmacology, National Yang Ming Chiao Tung University, Taipei, Taiwan
– name: 12 TRACTION Platform, Therapeutics Discovery Division, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
– name: 3 Department of Pediatrics, Baylor College of Medicine, Texas Children’s Hospital, Houston, Texas, United States of America
– name: 5 Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America
– name: 7 Department of Obstetrics & Gynecology and Women’s Health, Einstein/Montefiore Medical Center, New York City, New York, United States of America
– name: 11 Department of Neurology, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, United States of America
– name: 9 Center for Immunotherapy Research, Cancer Center of Excellence, Houston Methodist Research Institute, Houston, Texas, United States of America
– name: 4 Department of Neurobiology and Anatomy, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, United States of America
– name: 10 Department of Anesthesiology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas, United States of America
– name: 6 Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas, United States of America
– name: 13 Center for Stem Cell and Regenerative Medicine, The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, The University of Texas Health Science Center at Houston, Houston, Texas, United States of America
– name: St Jude Children’s Research Hospital, UNITED STATES
– name: 2 The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, United States of America
Author_xml – sequence: 1
  givenname: Brittany E.
  orcidid: 0000-0003-4483-5053
  surname: Jewell
  fullname: Jewell, Brittany E.
– sequence: 2
  givenname: An
  orcidid: 0000-0003-1776-7972
  surname: Xu
  fullname: Xu, An
– sequence: 3
  givenname: Dandan
  orcidid: 0000-0003-4609-1238
  surname: Zhu
  fullname: Zhu, Dandan
– sequence: 4
  givenname: Mo-Fan
  orcidid: 0000-0002-2209-1236
  surname: Huang
  fullname: Huang, Mo-Fan
– sequence: 5
  givenname: Linchao
  surname: Lu
  fullname: Lu, Linchao
– sequence: 6
  givenname: Mo
  orcidid: 0000-0001-8649-1514
  surname: Liu
  fullname: Liu, Mo
– sequence: 7
  givenname: Erica L.
  surname: Underwood
  fullname: Underwood, Erica L.
– sequence: 8
  givenname: Jun Hyoung
  surname: Park
  fullname: Park, Jun Hyoung
– sequence: 9
  givenname: Huihui
  orcidid: 0000-0003-4233-5389
  surname: Fan
  fullname: Fan, Huihui
– sequence: 10
  givenname: Julian A.
  surname: Gingold
  fullname: Gingold, Julian A.
– sequence: 11
  givenname: Ruoji
  orcidid: 0000-0001-7474-7156
  surname: Zhou
  fullname: Zhou, Ruoji
– sequence: 12
  givenname: Jian
  surname: Tu
  fullname: Tu, Jian
– sequence: 13
  givenname: Zijun
  surname: Huo
  fullname: Huo, Zijun
– sequence: 14
  givenname: Ying
  orcidid: 0000-0002-5178-1041
  surname: Liu
  fullname: Liu, Ying
– sequence: 15
  givenname: Weidong
  surname: Jin
  fullname: Jin, Weidong
– sequence: 16
  givenname: Yi-Hung
  orcidid: 0000-0001-8029-7323
  surname: Chen
  fullname: Chen, Yi-Hung
– sequence: 17
  givenname: Yitian
  surname: Xu
  fullname: Xu, Yitian
– sequence: 18
  givenname: Shu-Hsia
  orcidid: 0000-0002-9168-5775
  surname: Chen
  fullname: Chen, Shu-Hsia
– sequence: 19
  givenname: Nino
  orcidid: 0000-0002-6286-0095
  surname: Rainusso
  fullname: Rainusso, Nino
– sequence: 20
  givenname: Nathaniel K.
  orcidid: 0000-0002-2568-2867
  surname: Berg
  fullname: Berg, Nathaniel K.
– sequence: 21
  givenname: Danielle A.
  surname: Bazer
  fullname: Bazer, Danielle A.
– sequence: 22
  givenname: Christopher
  surname: Vellano
  fullname: Vellano, Christopher
– sequence: 23
  givenname: Philip
  orcidid: 0000-0001-6149-8293
  surname: Jones
  fullname: Jones, Philip
– sequence: 24
  givenname: Holger K.
  orcidid: 0000-0002-5676-6473
  surname: Eltzschig
  fullname: Eltzschig, Holger K.
– sequence: 25
  givenname: Zhongming
  orcidid: 0000-0002-3477-0914
  surname: Zhao
  fullname: Zhao, Zhongming
– sequence: 26
  givenname: Benny Abraham
  surname: Kaipparettu
  fullname: Kaipparettu, Benny Abraham
– sequence: 27
  givenname: Ruiying
  surname: Zhao
  fullname: Zhao, Ruiying
– sequence: 28
  givenname: Lisa L.
  orcidid: 0000-0002-2817-0832
  surname: Wang
  fullname: Wang, Lisa L.
– sequence: 29
  givenname: Dung-Fang
  orcidid: 0000-0003-2387-597X
  surname: Lee
  fullname: Lee, Dung-Fang
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34965247$$D View this record in MEDLINE/PubMed
BookMark eNqVk11rFDEUhgep2A_9ByIDgujFrskkk8x4IZTFj4ViS1u9DZnkzG5qJlmTTGkv_O9m3bV0RUTJRcLJ874JL-ccFnvOOyiKpxhNMeH49ZUfg5N2ulqAm2KE2pbjB8UBrmsy4RTRvXvn_eIwxiuESN20_FGxT2jL6oryg-L7mUwGXJpoCOYadGnOLmaxtMZ9LcHCtUy5Npjk1dI7HYy0ZYC4MkEmH25L5YeVhZtyXvajU8l4VyZf-pjARxnyrSyNK899Wg6j05PLpR9iZuJt9vIDPC4e9tJGeLLdj4rP799dzj5OTk4_zGfHJxPFOE0TaHGjm4oQhXtJak46aFEFpK91ralkknaIVS3WhCPOEVJdg2ijNOeENVwDOSrmG1_t5ZVYBTPIcCu8NOJnwYeFkCEZZUGoitAKKKt53VDo6o4QBLpTFBRAw7rs9XbjtRq7AbTK4QVpd0x3b5xZioW_Fg3HDNU4G7zcGgT_bYSYxGCiAmulAz9GUTFcU85wxTL6fIMuZP6acb3PjmqNi2OOWE0YqXimpn-g8tIwGJW7pje5viN4tSPITIKbtJBjjGJ-cf4f7Kd_Z0-_7LIv7rFLkDYto7fjuofiLvjsft53Qf_q4QzQDaCCjzFAf4dgJNajIrajItajIrajkmVvfpMpk-T6-ZyesX8X_wB03Rz8
CitedBy_id crossref_primary_10_14336_AD_2023_0924
crossref_primary_10_1016_j_jbc_2024_107494
crossref_primary_10_1158_2159_8290_CD_22_0882
crossref_primary_10_1016_j_gde_2024_102301
crossref_primary_10_3389_fimmu_2022_977235
crossref_primary_10_1089_cell_2023_29081_dfl
crossref_primary_10_3390_biom13111624
crossref_primary_10_1016_j_ejmg_2024_104941
crossref_primary_10_1016_j_isci_2023_108272
crossref_primary_10_1038_s41467_023_37398_9
Cites_doi 10.1093/jnci/95.9.669
10.1016/j.trecan.2016.07.007
10.1038/s41591-019-0608-y
10.3389/fcell.2019.00355
10.1158/1078-0432.CCR-17-3070
10.1038/s41389-018-0080-4
10.1007/978-3-030-43085-6_3
10.1073/pnas.1423008112
10.1073/pnas.0506580102
10.1016/j.cmet.2015.12.006
10.1016/j.cell.2020.07.039
10.1073/pnas.1814044115
10.1016/j.biocel.2012.07.016
10.1038/ng.806
10.1016/j.ajhg.2019.06.011
10.1038/s41591-018-0052-4
10.2183/pjab.85.348
10.1016/j.celrep.2014.03.037
10.1200/JCO.2006.08.4558
10.1016/j.stem.2012.05.020
10.1016/j.molmed.2017.06.004
10.1016/j.scr.2020.102006
10.1007/5584_2018_257
10.1038/nrc3038
10.1016/j.jmoldx.2018.09.008
10.1016/j.celrep.2015.09.019
10.1016/j.bbabio.2009.07.008
10.1073/pnas.1616035114
10.1016/j.semcdb.2017.08.011
10.1371/journal.pone.0013984
10.1146/annurev.biochem.75.103004.142539
10.1038/nbt.3178
10.1016/j.tips.2017.07.004
10.1016/j.cell.2015.02.045
10.1038/ng.471
10.3791/57664
10.1093/nar/gkq603
10.1093/hmg/ddn015
10.1016/j.cell.2006.07.024
10.1371/journal.pgen.1005932
10.1093/carcin/bgt315
10.1007/s11357-012-9476-9
10.1038/nm.4355
10.1007/978-3-319-04843-7_7
10.1038/nm.4238
10.18632/oncotarget.25166
10.1038/nbt.2514
10.1038/emm.2013.159
10.1016/j.scr.2018.10.003
10.1016/j.cell.2007.05.058
10.1186/s13059-014-0550-8
10.1093/nar/29.1.308
ContentType Journal Article
Copyright COPYRIGHT 2021 Public Library of Science
2021 Jewell et al 2021 Jewell et al
Copyright_xml – notice: COPYRIGHT 2021 Public Library of Science
– notice: 2021 Jewell et al 2021 Jewell et al
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISN
ISR
7X8
5PM
DOA
DOI 10.1371/journal.pgen.1009971
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Canada
Gale In Context: Science
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList CrossRef

MEDLINE



MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Aberrant mitochondrial respiratory complex I function in RTS
EISSN 1553-7404
ExternalDocumentID oai_doaj_org_article_c2342e4657584eb5b330edbc4ecee86b
PMC8716051
A706536327
34965247
10_1371_journal_pgen_1009971
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA253445
– fundername: NLM NIH HHS
  grantid: R01 LM012806
– fundername: NIDDK NIH HHS
  grantid: R01 DK109574
– fundername: NCI NIH HHS
  grantid: R01 CA234479
– fundername: NHLBI NIH HHS
  grantid: R01 HL154720
– fundername: NIGMS NIH HHS
  grantid: T32 GM120011
– fundername: NICHD NIH HHS
  grantid: K08 HD042136
– fundername: NIDDK NIH HHS
  grantid: R01 DK122796
– fundername: NICHD NIH HHS
  grantid: U54 HD083092
– fundername: NCRR NIH HHS
  grantid: M01 RR000188
– fundername: ;
– fundername: ;
  grantid: HD083092 via Clinical Translational Core and Tissue Culture Core of the Baylor College of Medicine Intellectual and Developmental Disabilities Research Center
– fundername: ;
  grantid: R01CA246130
– fundername: ;
  grantid: RR000188-42
– fundername: ;
  grantid: W81XWH-20-1-0389
– fundername: ;
  grantid: R01HL133900
– fundername: ;
  grantid: W81XWH-18-1-0714
– fundername: ;
  grantid: RR160019
– fundername: ;
  grantid: NIH T32GM120011
– fundername: ;
  grantid: HD42136
GroupedDBID ---
123
29O
2WC
53G
5VS
7X7
88E
8FE
8FH
8FI
8FJ
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
AEAQA
AENEX
AFKRA
AFPKN
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
B0M
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAP
EAS
EBD
EBS
EJD
EMK
EMOBN
ESX
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IGS
IHR
IHW
INH
INR
IOV
ISN
ISR
ITC
KQ8
LK8
M1P
M48
M7P
O5R
O5S
OK1
OVT
P2P
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PV9
QF4
QN7
RNS
RPM
RZL
SV3
TR2
TUS
UKHRP
WOW
XSB
~8M
ADRAZ
C1A
CGR
CUY
CVF
ECM
EIF
H13
IPNFZ
NPM
PJZUB
PPXIY
PQGLB
RIG
WOQ
PMFND
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c674t-e918d8233c1fa3573be902e3f5d5d4a6a4b06291d3707700cb8048cd773687de3
IEDL.DBID M48
ISSN 1553-7404
1553-7390
IngestDate Wed Aug 27 01:31:29 EDT 2025
Thu Aug 21 13:37:26 EDT 2025
Fri Jul 11 15:57:41 EDT 2025
Tue Jun 17 21:43:58 EDT 2025
Tue Jun 10 20:38:30 EDT 2025
Fri Jun 27 04:24:33 EDT 2025
Fri Jun 27 04:55:23 EDT 2025
Fri Jun 27 04:27:23 EDT 2025
Thu May 22 21:21:31 EDT 2025
Mon Jul 21 06:06:12 EDT 2025
Tue Jul 01 04:14:53 EDT 2025
Thu Apr 24 23:01:32 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c674t-e918d8233c1fa3573be902e3f5d5d4a6a4b06291d3707700cb8048cd773687de3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
The authors have declared that no competing interests exist.
ORCID 0000-0001-7474-7156
0000-0003-4233-5389
0000-0002-3477-0914
0000-0002-5676-6473
0000-0002-6286-0095
0000-0003-2387-597X
0000-0002-2568-2867
0000-0002-2209-1236
0000-0001-8649-1514
0000-0001-8029-7323
0000-0003-1776-7972
0000-0002-2817-0832
0000-0003-4483-5053
0000-0002-9168-5775
0000-0001-6149-8293
0000-0002-5178-1041
0000-0003-4609-1238
OpenAccessLink https://doaj.org/article/c2342e4657584eb5b330edbc4ecee86b
PMID 34965247
PQID 2615476126
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_c2342e4657584eb5b330edbc4ecee86b
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8716051
proquest_miscellaneous_2615476126
gale_infotracmisc_A706536327
gale_infotracacademiconefile_A706536327
gale_incontextgauss_ISR_A706536327
gale_incontextgauss_ISN_A706536327
gale_incontextgauss_IOV_A706536327
gale_healthsolutions_A706536327
pubmed_primary_34965247
crossref_primary_10_1371_journal_pgen_1009971
crossref_citationtrail_10_1371_journal_pgen_1009971
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-12-29
PublicationDateYYYYMMDD 2021-12-29
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-29
  day: 29
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco, CA USA
PublicationTitle PLoS genetics
PublicationTitleAlternate PLoS Genet
PublicationYear 2021
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References R Zhou (pgen.1009971.ref019) 2017; 38
TM Ashton (pgen.1009971.ref010) 2018; 24
DF Lee (pgen.1009971.ref043) 2007; 130
EP Papapetrou (pgen.1009971.ref014) 2016; 22
NF Ajeawung (pgen.1009971.ref005) 2019; 105
MI Love (pgen.1009971.ref044) 2014; 15
CJ Chen (pgen.1009971.ref055) 2019; 25
ST Sherry (pgen.1009971.ref052) 2001; 29
T Davis (pgen.1009971.ref036) 2013; 35
MA Sukhai (pgen.1009971.ref050) 2019; 21
A Subramanian (pgen.1009971.ref045) 2005; 102
NN Pavlova (pgen.1009971.ref009) 2016; 23
M Liu (pgen.1009971.ref015) 2018; 8
YH Lin (pgen.1009971.ref037) 2017; 23
D Merico (pgen.1009971.ref046) 2010; 5
DF Lee (pgen.1009971.ref017) 2015; 161
FJ Rouhani (pgen.1009971.ref026) 2016; 12
LM Phan (pgen.1009971.ref007) 2014; 11
Y Ma (pgen.1009971.ref056) 2010; 1797
F Bonnay (pgen.1009971.ref011) 2020; 182
Z Darzynkiewicz (pgen.1009971.ref054) 2001
WH Koppenol (pgen.1009971.ref008) 2011; 11
H Fang (pgen.1009971.ref028) 2018; 7
H Chae (pgen.1009971.ref039) 2014; 46
A Doi (pgen.1009971.ref048) 2009; 41
LL Wang (pgen.1009971.ref003) 1993
JR Molina (pgen.1009971.ref031) 2018; 24
U. Brandt (pgen.1009971.ref030) 2006; 75
K Cibulskis (pgen.1009971.ref049) 2013; 31
N Fusaki (pgen.1009971.ref024) 2009; 85
Z Chi (pgen.1009971.ref034) 2012; 44
L Lu (pgen.1009971.ref001) 2014; 804
EM Kwon (pgen.1009971.ref051) 2017; 114
LE Formosa (pgen.1009971.ref029) 2018; 76
HV Vangapandu (pgen.1009971.ref032) 2018; 9
LL Wang (pgen.1009971.ref004) 2003; 95
AG Kotini (pgen.1009971.ref021) 2015; 33
K Takahashi (pgen.1009971.ref025) 2006; 126
R Zhou (pgen.1009971.ref040) 2018
D Zhu (pgen.1009971.ref016) 2018; 1119
DF Lee (pgen.1009971.ref042) 2012; 11
MA DePristo (pgen.1009971.ref047) 2011; 43
S Mulero-Navarro (pgen.1009971.ref022) 2015; 13
MJ Hicks (pgen.1009971.ref006) 2007; 25
S Gupta (pgen.1009971.ref033) 2014; 35
LK Pang (pgen.1009971.ref020) 2020; 49
BE Jewell (pgen.1009971.ref041) 2018; 33
M Crespo (pgen.1009971.ref023) 2017; 23
J Gingold (pgen.1009971.ref013) 2016; 2
Q Zhao (pgen.1009971.ref027) 2015; 112
V Choesmel (pgen.1009971.ref038) 2008; 17
H Kim (pgen.1009971.ref018) 2018; 115
K Wang (pgen.1009971.ref053) 2010; 38
JT Wang (pgen.1009971.ref035) 2014; 7
L Lu (pgen.1009971.ref002) 2020; 1258
TV Denisenko (pgen.1009971.ref012) 2019; 7
References_xml – volume: 95
  start-page: 669
  issue: 9
  year: 2003
  ident: pgen.1009971.ref004
  article-title: Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thomson syndrome
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/95.9.669
– volume: 2
  start-page: 485
  issue: 9
  year: 2016
  ident: pgen.1009971.ref013
  article-title: Modeling Cancer with Pluripotent Stem Cells
  publication-title: Trends Cancer
  doi: 10.1016/j.trecan.2016.07.007
– volume: 25
  start-page: 1684
  issue: 11
  year: 2019
  ident: pgen.1009971.ref055
  article-title: Therapeutic inhibition of mTORC2 rescues the behavioral and neurophysiological abnormalities associated with Pten-deficiency
  publication-title: Nat Med
  doi: 10.1038/s41591-019-0608-y
– volume: 8
  start-page: 944
  issue: 6
  year: 2018
  ident: pgen.1009971.ref015
  article-title: Cancer in a dish: progress using stem cells as a platform for cancer research
  publication-title: Am J Cancer Res
– volume: 7
  start-page: 355
  year: 2019
  ident: pgen.1009971.ref012
  article-title: Mitochondrial Involvement in Migration, Invasion and Metastasis
  publication-title: Front Cell Dev Biol
  doi: 10.3389/fcell.2019.00355
– volume: 24
  start-page: 2482
  issue: 11
  year: 2018
  ident: pgen.1009971.ref010
  article-title: Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-17-3070
– volume: 7
  start-page: 68
  issue: 9
  year: 2018
  ident: pgen.1009971.ref028
  article-title: RecQL4-Aurora B kinase axis is essential for cellular proliferation, cell cycle progression, and mitotic integrity
  publication-title: Oncogenesis
  doi: 10.1038/s41389-018-0080-4
– volume: 1258
  start-page: 37
  year: 2020
  ident: pgen.1009971.ref002
  article-title: RECQ DNA Helicases and Osteosarcoma
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-3-030-43085-6_3
– volume: 112
  start-page: 530
  issue: 2
  year: 2015
  ident: pgen.1009971.ref027
  article-title: MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1423008112
– volume: 102
  start-page: 15545
  issue: 43
  year: 2005
  ident: pgen.1009971.ref045
  article-title: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0506580102
– volume: 23
  start-page: 27
  issue: 1
  year: 2016
  ident: pgen.1009971.ref009
  article-title: The Emerging Hallmarks of Cancer Metabolism
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2015.12.006
– volume: 182
  start-page: 1490
  issue: 6
  year: 2020
  ident: pgen.1009971.ref011
  article-title: Oxidative Metabolism Drives Immortalization of Neural Stem Cells during Tumorigenesis
  publication-title: Cell
  doi: 10.1016/j.cell.2020.07.039
– volume: 115
  start-page: E11128
  issue: 47
  year: 2018
  ident: pgen.1009971.ref018
  article-title: Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1814044115
– volume: 44
  start-page: 1942
  issue: 11
  year: 2012
  ident: pgen.1009971.ref034
  article-title: RecQL4 cytoplasmic localization: implications in mitochondrial DNA oxidative damage repair
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2012.07.016
– volume: 43
  start-page: 491
  issue: 5
  year: 2011
  ident: pgen.1009971.ref047
  article-title: A framework for variation discovery and genotyping using next-generation DNA sequencing data
  publication-title: Nat Genet
  doi: 10.1038/ng.806
– volume-title: Rothmund-Thomson Syndrome
  year: 1993
  ident: pgen.1009971.ref003
– volume: 105
  start-page: 625
  issue: 3
  year: 2019
  ident: pgen.1009971.ref005
  article-title: Mutations in ANAPC1, Encoding a Scaffold Subunit of the Anaphase-Promoting Complex, Cause Rothmund-Thomson Syndrome Type 1
  publication-title: Am J Hum Genet
  doi: 10.1016/j.ajhg.2019.06.011
– volume: 24
  start-page: 1036
  issue: 7
  year: 2018
  ident: pgen.1009971.ref031
  article-title: An inhibitor of oxidative phosphorylation exploits cancer vulnerability
  publication-title: Nat Med
  doi: 10.1038/s41591-018-0052-4
– volume: 85
  start-page: 348
  issue: 8
  year: 2009
  ident: pgen.1009971.ref024
  article-title: Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome
  publication-title: Proc Jpn Acad Ser B Phys Biol Sci
  doi: 10.2183/pjab.85.348
– volume: 7
  start-page: 848
  issue: 3
  year: 2014
  ident: pgen.1009971.ref035
  article-title: Impaired p32 regulation caused by the lymphoma-prone RECQ4 mutation drives mitochondrial dysfunction
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2014.03.037
– volume: 25
  start-page: 370
  issue: 4
  year: 2007
  ident: pgen.1009971.ref006
  article-title: Clinicopathologic features of osteosarcoma in patients with Rothmund-Thomson syndrome
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.08.4558
– volume: 11
  start-page: 179
  issue: 2
  year: 2012
  ident: pgen.1009971.ref042
  article-title: Regulation of embryonic and induced pluripotency by aurora kinase-p53 signaling
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2012.05.020
– volume: 23
  start-page: 737
  issue: 8
  year: 2017
  ident: pgen.1009971.ref037
  article-title: Osteosarcoma: Molecular Pathogenesis and iPSC Modeling
  publication-title: Trends Mol Med
  doi: 10.1016/j.molmed.2017.06.004
– volume: 49
  start-page: 102006
  year: 2020
  ident: pgen.1009971.ref020
  article-title: Modeling of osteosarcoma with induced pluripotent stem cells
  publication-title: Stem Cell Res
  doi: 10.1016/j.scr.2020.102006
– volume: 1119
  start-page: 169
  year: 2018
  ident: pgen.1009971.ref016
  article-title: Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling
  publication-title: Adv Exp Med Biol
  doi: 10.1007/5584_2018_257
– volume: 11
  start-page: 325
  issue: 5
  year: 2011
  ident: pgen.1009971.ref008
  article-title: Otto Warburg’s contributions to current concepts of cancer metabolism
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3038
– volume: 21
  start-page: 261
  issue: 2
  year: 2019
  ident: pgen.1009971.ref050
  article-title: Somatic Tumor Variant Filtration Strategies to Optimize Tumor-Only Molecular Profiling Using Targeted Next-Generation Sequencing Panels
  publication-title: J Mol Diagn
  doi: 10.1016/j.jmoldx.2018.09.008
– volume: 13
  start-page: 504
  issue: 3
  year: 2015
  ident: pgen.1009971.ref022
  article-title: Myeloid Dysregulation in a Human Induced Pluripotent Stem Cell Model of PTPN11-Associated Juvenile Myelomonocytic Leukemia
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2015.09.019
– volume: 1797
  start-page: 29
  issue: 1
  year: 2010
  ident: pgen.1009971.ref056
  article-title: Mitochondrial dysfunction in human breast cancer cells and their transmitochondrial cybrids
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbabio.2009.07.008
– volume: 11
  start-page: 1
  issue: 1
  year: 2014
  ident: pgen.1009971.ref007
  article-title: Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies
– volume: 114
  start-page: 1964
  issue: 8
  year: 2017
  ident: pgen.1009971.ref051
  article-title: iPSCs and fibroblast subclones from the same fibroblast population contain comparable levels of sequence variations
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1616035114
– volume: 76
  start-page: 154
  year: 2018
  ident: pgen.1009971.ref029
  article-title: Building a complex complex: Assembly of mitochondrial respiratory chain complex I
  publication-title: Semin Cell Dev Biol
  doi: 10.1016/j.semcdb.2017.08.011
– volume: 5
  start-page: e13984
  issue: 11
  year: 2010
  ident: pgen.1009971.ref046
  article-title: Enrichment map: a network-based method for gene-set enrichment visualization and interpretation
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0013984
– volume: 75
  start-page: 69
  year: 2006
  ident: pgen.1009971.ref030
  article-title: Energy converting NADH:quinone oxidoreductase (complex I)
  publication-title: Annu Rev Biochem
  doi: 10.1146/annurev.biochem.75.103004.142539
– volume: 33
  start-page: 646
  issue: 6
  year: 2015
  ident: pgen.1009971.ref021
  article-title: Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.3178
– volume: 38
  start-page: 908
  issue: 10
  year: 2017
  ident: pgen.1009971.ref019
  article-title: Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53
  publication-title: Trends Pharmacol Sci
  doi: 10.1016/j.tips.2017.07.004
– volume: 161
  start-page: 240
  issue: 2
  year: 2015
  ident: pgen.1009971.ref017
  article-title: Modeling familial cancer with induced pluripotent stem cells
  publication-title: Cell
  doi: 10.1016/j.cell.2015.02.045
– volume: 41
  start-page: 1350
  issue: 12
  year: 2009
  ident: pgen.1009971.ref048
  article-title: Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts
  publication-title: Nat Genet
  doi: 10.1038/ng.471
– issue: 136
  year: 2018
  ident: pgen.1009971.ref040
  article-title: Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
  publication-title: J Vis Exp
  doi: 10.3791/57664
– volume: 38
  start-page: e164
  issue: 16
  year: 2010
  ident: pgen.1009971.ref053
  article-title: ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkq603
– volume: 17
  start-page: 1253
  issue: 9
  year: 2008
  ident: pgen.1009971.ref038
  article-title: Mutation of ribosomal protein RPS24 in Diamond-Blackfan anemia results in a ribosome biogenesis disorder
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddn015
– volume: 126
  start-page: 663
  issue: 4
  year: 2006
  ident: pgen.1009971.ref025
  article-title: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
  publication-title: Cell
  doi: 10.1016/j.cell.2006.07.024
– volume: 12
  start-page: e1005932
  issue: 4
  year: 2016
  ident: pgen.1009971.ref026
  article-title: Mutational History of a Human Cell Lineage from Somatic to Induced Pluripotent Stem Cells
  publication-title: PLoS Genet
  doi: 10.1371/journal.pgen.1005932
– volume: 35
  start-page: 34
  issue: 1
  year: 2014
  ident: pgen.1009971.ref033
  article-title: RECQL4 and p53 potentiate the activity of polymerase gamma and maintain the integrity of the human mitochondrial genome
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/bgt315
– volume: 35
  start-page: 1767
  issue: 5
  year: 2013
  ident: pgen.1009971.ref036
  article-title: Activation of p38 MAP kinase and stress signalling in fibroblasts from the progeroid Rothmund-Thomson syndrome
  publication-title: Age (Dordr)
  doi: 10.1007/s11357-012-9476-9
– volume: 23
  start-page: 878
  issue: 7
  year: 2017
  ident: pgen.1009971.ref023
  article-title: Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing
  publication-title: Nat Med
  doi: 10.1038/nm.4355
– volume: 804
  start-page: 129
  year: 2014
  ident: pgen.1009971.ref001
  article-title: RECQ DNA helicases and osteosarcoma
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-3-319-04843-7_7
– volume: 22
  start-page: 1392
  issue: 12
  year: 2016
  ident: pgen.1009971.ref014
  article-title: Patient-derived induced pluripotent stem cells in cancer research and precision oncology
  publication-title: Nat Med
  doi: 10.1038/nm.4238
– volume: 9
  start-page: 24980
  issue: 38
  year: 2018
  ident: pgen.1009971.ref032
  article-title: Biological and metabolic effects of IACS-010759, an OxPhos inhibitor, on chronic lymphocytic leukemia cells
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.25166
– volume: 31
  start-page: 213
  issue: 3
  year: 2013
  ident: pgen.1009971.ref049
  article-title: Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.2514
– volume: 46
  start-page: e88
  year: 2014
  ident: pgen.1009971.ref039
  article-title: Ribosomal protein mutations in Korean patients with Diamond-Blackfan anemia
  publication-title: Exp Mol Med
  doi: 10.1038/emm.2013.159
– volume: 33
  start-page: 36
  year: 2018
  ident: pgen.1009971.ref041
  article-title: Generation of an induced pluripotent stem cell line from an individual with a heterozygous RECQL4 mutation
  publication-title: Stem Cell Res
  doi: 10.1016/j.scr.2018.10.003
– volume: 130
  start-page: 440
  issue: 3
  year: 2007
  ident: pgen.1009971.ref043
  article-title: IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway
  publication-title: Cell
  doi: 10.1016/j.cell.2007.05.058
– volume: 15
  start-page: 550
  issue: 12
  year: 2014
  ident: pgen.1009971.ref044
  article-title: Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
  publication-title: Genome Biol
  doi: 10.1186/s13059-014-0550-8
– year: 2001
  ident: pgen.1009971.ref054
  article-title: Determining cell cycle stages by flow cytometry
  publication-title: Curr Protoc Cell Biol
– volume: 29
  start-page: 308
  issue: 1
  year: 2001
  ident: pgen.1009971.ref052
  article-title: dbSNP: the NCBI database of genetic variation
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/29.1.308
SSID ssj0035897
Score 2.4347136
Snippet Rothmund-Thomson syndrome (RTS) is an autosomal recessive genetic disorder characterized by poikiloderma, small stature, skeletal anomalies, sparse...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e1009971
SubjectTerms Adenosine Triphosphate - biosynthesis
Analysis
Biology and Life Sciences
Care and treatment
Cell Proliferation - drug effects
Cell Respiration - drug effects
Cellular Senescence - genetics
Electron Transport Complex I - antagonists & inhibitors
Electron Transport Complex I - genetics
Gene expression
Gene Expression Regulation, Developmental - genetics
Genetic aspects
Humans
Induced Pluripotent Stem Cells - drug effects
Induced Pluripotent Stem Cells - metabolism
Medicine and Health Sciences
Mitogen-Activated Protein Kinase Kinases - genetics
Mutation - genetics
Osteoblasts - drug effects
Osteogenesis - genetics
Osteosarcoma
Osteosarcoma - complications
Osteosarcoma - genetics
Osteosarcoma - pathology
Oxadiazoles - pharmacology
Oxidative Phosphorylation - drug effects
Piperidines - pharmacology
RecQ Helicases - genetics
RNA, Long Noncoding - genetics
Rothmund-Thomson syndrome
Rothmund-Thomson Syndrome - complications
Rothmund-Thomson Syndrome - genetics
Rothmund-Thomson Syndrome - pathology
Stem cells
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuiDcLBQxC4mSa-BHHx1JRtRxK1VLUm-VXykpsUnV3ERz478zE2WUjDu2BazyJlJnxPDQz3xDyNjS1qWPhGfchMelLzowznDlTSCeNE0XoG2SPqoMz-elcnW-s-sKesAwPnBm3E7iQPEmsD9QyeeUhAU_RB5nAvNeVR-sLPm-VTGUbLFSd16ooJZiGtH4YmhO63Blk9P4SBIQ9AsbocuSUeuz-fy30hosat09u-KP9e-TuEEjS3fwD98mt1D4gt_NqyV8Pye_jDJjKIqjYjxTp9Ph0b06xXktxpBxCzEhncJ3B_LURtZBe_a26077TPP2khxQdHwqPLjqKAyHdHK5GN3N02tITEPNs2UaGbSUQuNMV_sEjcrb_8cveARtWLbBQablgyZR1rLkQoWycUFr4ZAqeRKOiitJVTvqi4qaMQhdaF0XwNVz9ELUWVa1jEo_JVtu16SmhELJVjQqmSQ4kF4Q3jVcVftylWMpyQsSK1zYMOOS4DuO77YtrGvKRzEGLErKDhCaErd-6zDgc19B_QDGuaRFFu38AumUH3bLX6daEvEIlsHkkdW0L7C7WhkUluJ6QNz0FImm02Kpz4ZbzuT38_PUGRKdHNyE6GRG9G4iaDngW3DBDAZxHGK8R5faIEoxGGB2_Xum1xSPstGtTt5xbyKiV1BD3VhPyJOv5mon9cgEu4W09ugEjLo9P2um3HrMc83Kw_8_-h1iekzscO4vArnCzTbYWV8v0AkLDhX_ZW4E_F7dk4w
  priority: 102
  providerName: Directory of Open Access Journals
Title Patient-derived iPSCs link elevated mitochondrial respiratory complex I function to osteosarcoma in Rothmund-Thomson syndrome
URI https://www.ncbi.nlm.nih.gov/pubmed/34965247
https://www.proquest.com/docview/2615476126
https://pubmed.ncbi.nlm.nih.gov/PMC8716051
https://doaj.org/article/c2342e4657584eb5b330edbc4ecee86b
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjR3LbtNAcFVaIXFBvBsoYUFInFzZu2uv94BQW7VqkQhRSlBu1r5cIjV2iRPUHvh3Zmwn1AJErtlZy5n3eF6EvLV5qlIXmoAZ6wNhIhYorVigVSi0UJqHti6QHSSnY_FxEk-2yGpna4vA6q-hHe6TGs8v96-_33wAgX9fb22Q0erS_hWgHLP-SmFT-Q7YJomi-kms8wo8Tpt1K3HMAwnhfttM96-ndIxVPdP_T819y3R1yypv2amTB-R-62DSg4YjHpItXzwid5uVkzePyc9hM0g1cMB6P7yj0-H5UUUxj0ux1RxcT0dnIOaAmcIhd9L572w8rSvQ_TU9o2gQkah0UVJsFCkrEJlypum0oCMg_2xZuADLTcChp6u5CE_I-OT4y9Fp0K5gCGwixSLwKkpdyji3Ua55LLnxKmSe57GLndCJFiZMmIocl6GUYWhNCirBOil5kkrn-VOyXZSF3yUUXLkkj63KveaCWW5UbuIEH669i0TUI3yF68y288lxTcZlVifdJMQpDQYzpFDWUqhHgvWtq2Y-x3_gD5GMa1icrl3_UM4vslZYM8vgDb3AnFQqvIkN56F3xgoPLkWamB55hUyQNa2qax2RHWDOmCecyR55U0PghI0CS3gu9LKqsrPPXzcAOh9sAjTqAL1rgfIScGZ121sBmMfxXh3IvQ4kKBPbOX694usMj7ACr_Dlssog0o6FBH846ZFnDZ-vkVgvHWACbsuOBHSw3D0ppt_qWeYYr4NdeL7xH3hB7jEsKwKlwtQe2V7Ml_4l-IUL0yd35ET2yc7h8WA46tdfV_q1-P8C-2Fo7g
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Patient-derived+iPSCs+link+elevated+mitochondrial+respiratory+complex+I+function+to+osteosarcoma+in+Rothmund-Thomson+syndrome&rft.jtitle=PLoS+genetics&rft.au=Jewell%2C+Brittany+E&rft.au=Xu%2C+An&rft.au=Zhu%2C+Dandan&rft.au=Huang%2C+Mo-Fan&rft.date=2021-12-29&rft.pub=Public+Library+of+Science&rft.issn=1553-7390&rft.volume=17&rft.issue=12&rft_id=info:doi/10.1371%2Fjournal.pgen.1009971&rft.externalDocID=A706536327
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1553-7404&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1553-7404&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1553-7404&client=summon